(Q72589092)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Placebo-controlled double-blind trial of ketanserin in treatment of intermittent claudication (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

intermittent claudication

1 reference

1 reference

J. De Cree

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148522

15 August 2023

J. Leempoels

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148522

15 August 2023

H. Geukens

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148522

15 August 2023

H. Verhaegen

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6148522

15 August 2023

language of work or name

English

0 references

publication date

1 October 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

6 October 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6148522

full work available at URL

15 August 2023

https://api.elsevier.com/content/article/PII:S0140673684907049?httpAccept=text/xml

1 reference

10.1016/S0140-6736(84)90704-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(84)90704-9

https://api.elsevier.com/content/article/PII:S0140673684907049?httpAccept=text/plain

15 August 2023

1 reference

10.1016/S0140-6736(84)90704-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(84)90704-9

15 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

775-779

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Impaired red cell deformability in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

The Rheological Effects of Cinnarizine and Flunarizine in Normal and Pathologic Conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Platelet activation during exercise-induced myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Acute blood-pressure-lowering effect of ketanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

5-HT2-receptor blockade in the treatment of heart failure. A preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

A comparative study of the reactive hyperemia in diabetes and intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

Reactive hyperemia in patients with intermittent claudication, and correlation with other diagnostic methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

The injury-spasm (ischemia-induced hemostatic vasoconstrictive) and vascular autoregulatory hypothesis of ischemic disease. Resistance vessel-spasm hypothesis of ischemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990704-9

7 January 2021

10.1016/S0140-6736(84)90704-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6148522%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference